Dr. Chris Atherton

Commercial Director
Onyx Scientific Ltd.
Chris joined Onyx Scientific in 2002 following completion of a PhD in synthetic organic chemistry and has developed a wealth of experience in process development, scale-up and GMP regulatory matters through his roles as a development chemist and Team Leader. Latterly, he has moved into managerial and leadership roles, including Commercial Director, and is responsible for all commercial operations at Onyx, such as business development, marketing and ensuring high levels of service for clients.

Articles by Dr. Chris Atherton

  • Rethinking Early-Phase Outsourcing

    Monday, September 21, 2026
    The CDMOs that bridge the fulfilment gap and truly become partners are likely the best choice for biotechs and pharma looking to develop their early-stage asset. While most CDMOs are well-versed in providing services with regular communication, ...
  • <<
  • >>